Literature DB >> 21598082

Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.

Ziyaur Rahman1, Cyrus Agarabi, Ahmed S Zidan, Saeed R Khan, Mansoor A Khan.   

Abstract

The focus of this investigation was to prepare the cocrystal of carbamazepine (CBZ) using nicotinamide as a coformer and to compare its preformulation properties and stability profile with CBZ. The cocrystal was prepared by solution cooling crystallization, solvent evaporation, and melting and cryomilling methods. They were characterized for solubility, intrinsic dissolution rate, chemical identification by Fourier transform infrared spectroscopy, crystallinity by differential scanning calorimetry, powder X-ray diffraction, and morphology by scanning electron microscopy. Additionally, mechanical properties were evaluated by tensile strength and Heckel analysis of compacts. The cocrystal and CBZ were stored at 40°C/94% RH, 40°C/75% RH, 25°C/60% RH, and 60°C to determine their stability behavior. The cocrystals were fluffy, with a needle-shaped crystal, and were less dense than CBZ. The solubility profiles of the cocrystals were similar to CBZ, but its intrinsic dissolution rate was lower due to the high tensile strength of its compacts. Unlike CBZ, the cocrystals were resistant to hydrate transformation, as revealed by the stability studies. Plastic deformation started at a higher compression pressure in the cocrystals than CBZ, as indicated by the high yield pressure. In conclusion, the preformulation profile of the cocrystals was similar to CBZ, except that it had an advantageous resistance to hydrate transformation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598082      PMCID: PMC3134642          DOI: 10.1208/s12249-011-9603-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

1.  Solid-state study of polymorphic drugs: carbamazepine.

Authors:  C Rustichelli; G Gamberini; V Ferioli; M C Gamberini; R Ficarra; S Tommasini
Journal:  J Pharm Biomed Anal       Date:  2000-08-01       Impact factor: 3.935

2.  Reaction crystallization of pharmaceutical molecular complexes.

Authors:  Naír Rodríguez-Hornedo; Sarah J Nehm; Kurt F Seefeldt; Yomaira Pagan-Torres; Christopher J Falkiewicz
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

3.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

4.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate.

Authors:  Y Kobayashi; S Ito; S Itai; K Yamamoto
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

5.  Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Mansoor A Khan
Journal:  AAPS J       Date:  2010-02-03       Impact factor: 4.009

6.  Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.

Authors:  Julius F Remenar; Matthew L Peterson; Peter W Stephens; Zhong Zhang; Yuri Zimenkov; Magali B Hickey
Journal:  Mol Pharm       Date:  2007-05-12       Impact factor: 4.939

7.  Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.

Authors:  K Seefeldt; J Miller; F Alvarez-Núñez; N Rodríguez-Hornedo
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

8.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.

Authors:  Adam L Grzesiak; Meidong Lang; Kibum Kim; Adam J Matzger
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

9.  Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.

Authors:  P Granger; B Biton; C Faure; X Vige; H Depoortere; D Graham; S Z Langer; B Scatton; P Avenet
Journal:  Mol Pharmacol       Date:  1995-06       Impact factor: 4.436

10.  Polymorphism in Carbamazepine Cocrystals.

Authors:  William W Porter; Sophia C Elie; Adam J Matzger
Journal:  Cryst Growth Des       Date:  2008       Impact factor: 4.076

View more
  12 in total

1.  Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization.

Authors:  Kun Ma; Ying Zhang; Hongliang Kan; Linfeng Cheng; Ling Luo; Qing Su; Jing Gao; Yuan Gao; Jianjun Zhang
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

2.  Novel Co-crystals and Eutectics of Febuxostat: Characterization, Mechanism of Formation, and Improved Dissolution.

Authors:  Moksh Jagia; Dnyaneshwar P Kale; Arvind Kumar Bansal; Sarsvatkumar Patel
Journal:  AAPS PharmSciTech       Date:  2021-12-29       Impact factor: 3.246

3.  A Brief Discussion of Multi-Component Organic Solids: Key Emphasis on Co-Crystallization

Authors:  Braham Dutt; Manjusha Choudhary; Vikas Budhwar
Journal:  Turk J Pharm Sci       Date:  2022-04-29

4.  Identification of New Cocrystal Systems with Stoichiometric Diversity of Salicylic Acid Using Thermal Methods.

Authors:  Zhengzheng Zhou; Hok Man Chan; Herman H-Y Sung; Henry H Y Tong; Ying Zheng
Journal:  Pharm Res       Date:  2016-01-07       Impact factor: 4.200

5.  Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.

Authors:  Prabhakar Panzade; Giridhar Shendarkar
Journal:  Turk J Pharm Sci       Date:  2019-07-10

6.  Formulation and Solid State Characterization of Nicotinamide-based Co-crystals of Fenofibrate.

Authors:  Sheetal Shewale; A S Shete; R C Doijad; S S Kadam; V A Patil; A V Yadav
Journal:  Indian J Pharm Sci       Date:  2015 May-Jun       Impact factor: 0.975

7.  Freeze Dried Quetiapine-Nicotinamide Binary Solid Dispersions: A New Strategy for Improving Physicochemical Properties and Ex Vivo Diffusion.

Authors:  Ahmed Mahmoud Abdelhaleem Ali; Mayyas Mohammad Ahmad Al-Remawi
Journal:  J Pharm (Cairo)       Date:  2016-11-30

8.  Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.

Authors:  Prabhakar Panzade; Giridhar Shendarkar; Sarfaraj Shaikh; Pavan Balmukund Rathi
Journal:  Adv Pharm Bull       Date:  2017-09-25

Review 9.  Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Authors:  Anna Karagianni; Maria Malamatari; Kyriakos Kachrimanis
Journal:  Pharmaceutics       Date:  2018-01-25       Impact factor: 6.321

10.  Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation.

Authors:  Ahmad Ainurofiq; Rachmat Mauludin; Diky Mudhakir; Sundani Nurono Soewandhi
Journal:  Res Pharm Sci       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.